PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer
dc.contributor.author | Hui, R. | |
dc.contributor.author | Antonia, S. J. | |
dc.contributor.author | Villegas, A. | |
dc.contributor.author | Daniel, D. | |
dc.contributor.author | Baz, D. Vincente | |
dc.contributor.author | Murakami, S. | |
dc.contributor.author | Yokoi, T. | |
dc.contributor.author | Chiappori, A. | |
dc.contributor.author | Lee, K. H. | |
dc.contributor.author | de Wit, M. | |
dc.contributor.author | Cho, B. C. | |
dc.contributor.author | Bourhaba, M. | |
dc.contributor.author | Quantin, X. | |
dc.contributor.author | Tokito, T. | |
dc.contributor.author | Mekhail, T. | |
dc.contributor.author | Planchard, D. | |
dc.contributor.author | Jiang, H. | |
dc.contributor.author | Huang, Y. | |
dc.contributor.author | Dennis, P. A. | |
dc.contributor.author | Ozguroglu, M. | |
dc.date.accessioned | 2021-03-05T19:00:13Z | |
dc.date.available | 2021-03-05T19:00:13Z | |
dc.identifier.citation | Antonia S. J. , Villegas A., Daniel D., Baz D. V. , Murakami S., Hui R., Yokoi T., Chiappori A., Lee K. H. , de Wit M., et al., "PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer", 59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO), California, Amerika Birleşik Devletleri, 24 - 27 Eylül 2017, cilt.99, ss.1314-1315 | |
dc.identifier.other | av_cd266ef0-a499-4210-8f0c-6bf3096ca589 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/135772 | |
dc.language.iso | eng | |
dc.subject | Nükleer Tıp | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.title | PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer | |
dc.type | Bildiri | |
dc.contributor.department | H Lee Moffitt Cancer Center & Research Institute , , | |
dc.identifier.volume | 99 | |
dc.contributor.firstauthorID | 152608 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]